Iterum Therapeutics (ITRM)
(Real Time Quote from BATS)
$1.49 USD
-0.18 (-10.78%)
Updated Apr 29, 2024 03:56 PM ET
After-Market: $1.52 +0.03 (2.01%) 4:14 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/10/24 |
---|---|
Current Quarter | -0.57 |
EPS Last Quarter | -0.94 |
Last EPS Surprise | 7.84% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.75 |
Next Year | -1.27 |
EPS (TTM) | -2.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 0.93M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 0.93M |
Low Estimate | NA | NA | NA | 0.93M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.57 | -0.50 | -1.75 | -1.27 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.57 | -0.50 | -1.75 | -1.27 |
High Estimate | -0.57 | -0.50 | -1.75 | -1.27 |
Low Estimate | -0.57 | -0.50 | -1.75 | -1.27 |
Year ago EPS | -0.78 | -0.95 | -2.96 | -1.75 |
Year over Year Growth Est. | 26.92% | 47.37% | 40.88% | 27.43% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.57 | -0.50 | -1.75 | -1.27 |
7 Days Ago | -0.57 | -0.50 | -1.75 | -1.27 |
30 Days Ago | -0.88 | -0.87 | -3.05 | -1.82 |
60 Days Ago | -0.88 | -0.87 | -3.05 | -1.82 |
90 Days Ago | -0.88 | -0.87 | -3.05 | -4.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.57 | -0.50 | -1.75 | -1.27 |
Zacks Consensus Estimate | -0.57 | -0.50 | -1.75 | -1.27 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.94 | -0.30 | -0.95 | -0.78 | NA |
Estimate | -1.02 | -0.91 | -0.80 | -0.80 | NA |
Difference | 0.08 | 0.61 | -0.15 | 0.02 | 0.14 |
Surprise | 7.84% | 67.03% | -18.75% | 2.50% | 14.66% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more